ArticleACR open rheumatology2025

Understanding Cardiovascular Events With JAK Inhibitors: Tofacitinib Reduces Synovial and Vascular Inflammation but not the Prothrombotic Effects of Inflammatory Cytokines on Endothelium.

Aliki Zavoriti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.